Oragenics Inc (NASDAQ:OGEN) shares are trading lower by 45.5% to $0.58 during Wednesday’s session after the company announced ...

Investment analysts at StockNews.com assumed coverage on shares of Oragenics (NYSE:OGEN – Get Free Report) in a report issued on Saturday. The firm set a “sell” rating on the stock. Oragenics Stock ...

Dec. 16, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE: OGEN), a biotechnology company ... A and Series B Preferred Shares into common stock. The conversion helps simplify the company’s capital ...

Equities research analysts at StockNews.com started coverage on shares of Oragenics (NYSE:OGEN – Get Free Report) in a report issued on Friday. The firm set a “sell” rating on the stock. Oragenics ...

With over 5 million concussions occurring annually in the U.S. alone, there is a significant unmet need for effective diagnostic and therapeutic solutions. This partnership positions Oragenics and ...

Oragenics (OGEN) announced a strategic partnership with BRAINBox Solutions. This collaboration seeks to develop the first intranasal therapy ...

We have all of the hottest stock market news traders need to know about on Wednesday! That includes what’s going on with Oragenics (NYSEMKT:OGEN) stock, Beyond Meat (NASDAQ:BYND) stock and ...

On Tuesday, Oragenics Inc. (NYSE:OGEN) said it has completed a key study for its new concussion drug, ONP-002. What Happened: A recent study shows that the drug successfully targets areas inside ...